Bailard’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-36,632
Closed -$107K 771
2022
Q2
$107K Buy
+36,632
New +$107K ﹤0.01% 649